News & Events
Check back here for regular news updates, event information and press releases.
The bulletin lists advice and guidance published by us and other health technology assessment (HTA) agencies across the UK and Europe from November 2020 to January 2021.
In their introduction of the report, Professor Peter Groves, HTW Chair, and Dr Susan Myles, HTW Director, reflect with their thoughts on a challenging year that forced everyone across the health and social care landscape to think differently.
We appraised the clinical and cost effectiveness of TAVI for the treatment of patients with severe symptomatic aortic stenosis who are at intermediate surgical risk.
We appraised the clinical and cost effectiveness of RADT for group A streptococcal infections to treat people with a sore throat in the community pharmacy setting.